Zimmer Biomet Holdings Inc  

(Public, NYSE:ZBH)   Watch this stock  
Find more results for Dental One, Inc.�
+2.39 (2.37%)
Aug 27 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 100.92 - 103.45
52 week 94.73 - 121.84
Open 100.96
Vol / Avg. 1.47M/1.33M
Mkt cap 20.54B
P/E 52.13
Div/yield 0.22/0.85
EPS 1.98
Shares 203.37M
Beta 1.01
Inst. own 77%
Oct 21, 2015
Q3 2015 Zimmer Biomet Holdings Inc Earnings Release (Estimated) - 7:00AM EDT - Add to calendar
Jul 30, 2015
Q2 2015 Zimmer Biomet Holdings Inc Earnings Call
Jul 30, 2015
Q2 2015 Zimmer Holdings Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin -13.55% 15.39%
Operating margin -11.09% 22.14%
EBITD margin - 37.81%
Return on average assets -2.86% 7.48%
Return on average equity -7.59% 11.24%
Employees 10,000 -
CDP Score - 58 E


345 E Main St
WARSAW, IN 46580-2746
United States - Map
+1-574-2676131 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc. is a musculoskeletal healthcare company. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company manages its operations through three geographic segments: the Americas, comprising principally of the United States and includes other North, Central and South American markets; Europe, comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific, comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions, such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers, and directly to dental practices and dental laboratories.

Officers and directors

David C. Dvorak President, Chief Executive Officer, Director
Age: 51
Bio & Compensation  - Reuters
Daniel P. Florin Chief Financial Officer, Senior Vice President
Age: 51
Bio & Compensation  - Reuters
Joseph A. Cucolo President, Americas
Age: 55
Bio & Compensation  - Reuters
Katarzyna Mazur-Hofsaess M.D., Ph.D. President, Europe, Middle East and Africa
Age: 51
Bio & Compensation  - Reuters
Chad F. Phipps Senior Vice President, General Counsel, Secretary
Age: 43
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Tony W. Collins Chief Accounting Officer, Vice President, Controller
Age: 46
Bio & Compensation  - Reuters
Derek M. Davis Vice President - Global Integration
Age: 46
Bio & Compensation  - Reuters
Larry C. Glasscock Independent Non-Executive Chairman of the Board
Age: 67
Bio & Compensation  - Reuters
Michael J. Farrell Director
Age: 42
Bio & Compensation  - Reuters
Michael W. Michelson Director
Age: 63
Bio & Compensation  - Reuters